Background
Preventing injection
drug use among vulnerable youth is critical for reducing serious drug-related
harms. Addiction treatment is one evidence-based intervention to decrease
problematic substance use; however, youth frequently report being unable to
access treatment services and the impact of this on drug use trajectories
remains largely unexplored. This study examines the relationship between being
unable to access addiction treatment and injection initiation among
street-involved youth.
Methods
Data were derived from
the At-Risk Youth Study (ARYS), a prospective cohort of street-involved youth
aged 14–26 who use illicit drugs, from September 2005 to May 2014. An extended
Cox model with time-dependent variables was used to identify factors independently
associated with injection initiation.
Results
Among 462 participants
who were injection naïve at baseline, 97 (21 %) initiated injection drug
use over study follow-up and 129 (28 %) reported trying but being unable
to access addiction treatment in the previous 6 months at some point during the
study period. The most frequently reported reason for being unable to access
treatment was being put on a wait list. In a multivariable Cox regression
analysis, being unable to access addiction treatment remained independently
associated with a more rapid rate of injection initiation (Adjusted Hazard
Ratio =2.02; 95 % Confidence Interval: 1.12–3.62), after adjusting for
potential confounders.
Conclusion
Inability to access
addiction treatment was common among our sample and associated with injection
initiation. Findings highlight the need for easily accessible, evidence-based
addiction treatment for high-risk youth as a means to prevent injection
initiation and subsequent serious drug-related harms.
Full article at: http://goo.gl/JGP3DX
By: Kora DeBeck, Thomas Kerr, Seonaid Nolan, Huiru Dong, Julio Montaner, and Evan Wood
British Columbia
Centre for Excellence in HIV/AIDS, Vancouver, Canada
School of Public
Policy, Simon Fraser University, Vancouver, Canada
Division of AIDS,
Department of Medicine, University of British Columbia, Vancouver, Canada
Kora DeBeck, Phone: (604) 558-6679, Email: ac.cbu.tenefc@dk-ihru.
More at: https://twitter.com/hiv
insight
No comments:
Post a Comment